NDA 017433 · Davis and Geck
Pre-Op Ii
Hexachlorophene · Topical
Last checked: Nov 20, 2026Latest source record: May 7, 1992 (newest FDA action)Source: Drugs@FDA, openFDA, CMS, ClinicalTrials.gov, PubMedMethods & limitations
First approved
1978
Oct 12, 1978
Approved uses
1
Original approval plus efficacy supplements
Registered trials
2
0 Phase 3, 0 recruiting
FAERS reports
0
0 serious, 0 with death reported
AI brief across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, FAERS and PubMed data on this page, plus web searches for pricing, exclusivity and pending FDA decisions.
What it is approved for
No structured label for this application in openFDA. Older and discontinued products often have none.
Approval history
Original approval and efficacy supplements (new uses, populations or doses), newest first, with FDA's letters and labels.
- Oct 12, 1978 Original approval · Type 5 - New Formulation or New Manufacturer
2 products under this application
- PRE-OP II · HEXACHLOROPHENE 480MG · SPONGE, TOPICAL · Prescription · TE AT
- PRE-OP · HEXACHLOROPHENE 480MG · SPONGE, TOPICAL · Prescription · TE AT
Clinical trials
Interventional ClinicalTrials.gov studies with "Hexachlorophene" as an intervention, any sponsor and status, largest first.
- Prospective Study of Methicillin-Resistant Staphylococcus Aureus (MRSA) Among HIV-Infected PersonsPivotal-lookingCompleted
Henry M. Jackson Foundation for the Advancement of Military MedicineAcademic, hospital or other
NCT00631566 · 550 participants · Start May 2007 · Primary completion May 2017
Drug: Mupirocin (Bactroban) 2%; hexachlorophene (pHisoHex) 3%; Placebo · For: HIV Infections; Staphylococcal Infections
Sites: San Diego, California; Bethesda, Maryland; San Antonio, Texas · 4 sites in all
Natividad Medical CenterAcademic, hospital or other
NCT01049438 · 31 participants · Start Aug 2006 · Primary completion Sep 2009
Drug: nasal mupirocin; topical 3% hexachlorophene body wash and 1 more · For: Methicillin Resistant Staphylococcus Aureus Skin Infections
Most reported adverse reactions
FAERS reports naming this application or brand. Unverified reports, not rates; a report can name several drugs.
No FAERS reports name this application.
FAERS reports by year
By the date FDA received the report.
No reports.
Recalls
0 FDA enforcement reports for this application.
No recalls on record for this application.
Shortages
FDA's drug shortage list.
Not on FDA's shortage list.
Medicare spending
CMS Spending by Drug. Part D is pharmacy-dispensed; Part B is given in a clinic or hospital outpatient setting. Spending is before manufacturer rebates.
Not found under this brand name in Medicare's Part D or Part B Spending by Drug data. CMS lists some drugs under the generic name only.
Published evidence
PubMed clinical trials, meta-analyses and systematic reviews, most relevant first.
- Randomized trial of a hexachlorophene preparation and P-300 bacteriostatic soaps.
Bodey GP, Ebersole R, Hong HC · J Invest Dermatol 1976 · Clinical Trial, Comparative Study
- Recurrent staphylococcal infection in families.
Steele RW · Arch Dermatol 1980 · Clinical Trial, Controlled Clinical Trial
- [Urinary mercury excretion in professional users of an antiseptic soap containing 0,04% phenylmercury borate].
Peters-Haefeli L, Michod J, Aellig A, et al. · Schweiz Med Wochenschr 1976 · Clinical Trial, Controlled Clinical Trial
- Randomized, Double-Blind, Placebo-Controlled Study on Decolonization Procedures for Methicillin-Resistant Staphylococcus aureus (MRSA) among HIV-Infected Adults.
Weintrob A, Bebu I, Agan B, et al. · PLoS One 2015 · Randomized Controlled Trial, Research Support, N.I.H., Extramural
- Hexachlorophene concentrations in the blood of operating room personnel.
Butcher HR, Ballinger WF, Gravens DL, et al. · Arch Surg 1973 · Clinical Trial, Randomized Controlled Trial
- [Antisepsis with a hexachlorophene-based emulsion in perineal care in obstetrics (apropos of a continuous series in the hospital of 103 cases with triangular suture)].
Notter A, Martin M · Lyon Med 1967 · Clinical Trial
Sponsor: Davis and Geck · Also marketed as Pre-Op
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.